دورية أكاديمية

Clinical Consensus Guideline on the Management of Phaeochromocytoma and Paraganglioma in Patients Harbouring Germline SDHD Pathogenic Variants

التفاصيل البيبلوغرافية
العنوان: Clinical Consensus Guideline on the Management of Phaeochromocytoma and Paraganglioma in Patients Harbouring Germline SDHD Pathogenic Variants
المؤلفون: Taïeb, David, Wanna, George B, Ahmad, Maleeha, Lussey-Lepoutre, Charlotte, Perrier, Nancy D, Nölting, Svenja, Amar, Laurence, Timmers, Henri J L M, Schwam, Zachary G, Estrera, Anthony L, Lim, Michael, Pollom, Erqi Liu, Vitzthum, Lucas, Bourdeau, Isabelle, Casey, Ruth T, Castinetti, Frédéric, Clifton-Bligh, Roderick, Corssmit, Eleonora P M, de Krijger, Ronald R, Del Rivero, Jaydira, Eisenhofer, Graeme, Ghayee, Hans K, Gimenez-Roqueplo, Anne-Paule, Grossman, Ashley, Imperiale, Alessio, Jansen, Jeroen C, Jha, Abhishek, Kerstens, Michiel N, Kunst, Henricus P M, Liu, James K, Maher, Eamonn R, Marchioni, Daniele, Mercado-Asis, Leilani B, Mete, Ozgur, Naruse, Mitsuhide, Nilubol, Naris, Pandit-Taskar, Neeta, Sebag, Frédéric, Tanabe, Akiyo, Widimsky, Jiri, Meuter, Leah, Lenders, Jacques W M, Pacak, Karel
المصدر: Journal Articles
بيانات النشر: DigitalCommons@TMC
سنة النشر: 2023
المجموعة: Houston Academy of Medicine-Texas Medical Center (HAM-TMC): DigitalCommons@The Texas Medical Center
مصطلحات موضوعية: paragangliomas, genetics, guidelines, management, surgery, radiotherapy, SDHD, Humans, Adrenal Gland Neoplasms, Germ-Line Mutation, Paraganglioma, Pheochromocytoma, Succinate Dehydrogenase, Practice Guidelines as Topic, Cardiology, Cardiovascular Diseases, Diseases, Endocrine System Diseases, Endocrinology, Diabetes, and Metabolism, Medical Specialties, Medicine and Health Sciences
الوصف: Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck paragangliomas, which, in almost 20% of patients, might coexist with paragangliomas arising from other locations (eg, adrenal medulla, para-aortic, cardiac or thoracic, and pelvic). Given the higher risk of tumour multifocality and bilaterality for phaeochromocytomas and paragangliomas (PPGLs) because of SDHD pathogenic variants than for their sporadic and other genotypic counterparts, the management of patients with SDHD PPGLs is clinically complex in terms of imaging, treatment, and management options. Furthermore, locally aggressive disease can be discovered at a young age or late in the disease course, which presents challenges in balancing surgical intervention with various medical and radiotherapeutic approaches. The axiom-first, do no harm-should always be considered and an initial period of observation (ie, watchful waiting) is often appropriate to characterise tumour behaviour in patients with these pathogenic variants. These patients should be referred to specialised high-volume medical centres. This consensus guideline aims to help physicians with the clinical decision-making process when caring for patients with SDHD PPGLs.
نوع الوثيقة: text
وصف الملف: application/pdf
اللغة: unknown
العلاقة: https://digitalcommons.library.tmc.edu/uthmed_docs/948Test; https://digitalcommons.library.tmc.edu/context/uthmed_docs/article/1938/viewcontent/nihms_1891894.pdfTest
الإتاحة: https://digitalcommons.library.tmc.edu/uthmed_docs/948Test
https://digitalcommons.library.tmc.edu/context/uthmed_docs/article/1938/viewcontent/nihms_1891894.pdfTest
رقم الانضمام: edsbas.DF71D2A8
قاعدة البيانات: BASE